Insider Transactions in Q4 2024 at Neoleukin Therapeutics, Inc. (NLTX)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 26
2024
|
Samsara Bio Capital Gp, LLC |
BUY
Open market or private purchase
|
Indirect |
48,770
+0.71%
|
$1,268,020
$26.29 P/Share
|
|
Nov 22
2024
|
Rachel Mc Minn Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
47,500
+3.53%
|
$950,000
$20.4 P/Share
|
|
Nov 22
2024
|
Christine Mikail Cvijic President and CFO |
BUY
Open market or private purchase
|
Direct |
24,000
+23.8%
|
$480,000
$20.48 P/Share
|